{"GHMDC classification":["Diagnosis"],"GHMDC health topic":["Maternal mortality"],"GHMDC manufacturer coordinates":["55.00125, -97.001038888889"],"GHMDC manufacturer location":["Manitoba, Canada"],"Page SDG":["SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/Miraculins_Biomarker"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["Pre-eclampsia affects over three million mothers worldwide each year and is also associated with premature birth. Regular blood pressure (BP) monitoring is a cost-effective means of identifying hypertensive diseases in their early stages. However, there are currently no effective ways to detect a women's likelihood to suffer from pre-eclampsia prior to developing the condition."],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/Miraculins Biomarker"],"Page views":[32],"Page year":["Tuesday, 01-Jan-13 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 14:50:55 UTC"]}